Neonatal Cystic Fibrosis Screening
Alternate Names : Cystic Fibrosis Screening - Neonatal, Immunoreactive Trypsinogen
Definition
Neonatal cystic fibrosis screening involves a pancreatic test that evaluates immunoreactive trypsinogen. The test is performed on newborns to determine whether the baby has cystic fibrosis (CF).
Pictures & Images
 See all Pictures & Images
Why is the Test Performed?
Cystic fibrosis is a genetic disease that affects the sweat glands as well as the respiratory and gastrointestinal systems. Trypsinogen is produced by the pancreas and is elevated in babies with cystic fibrosis. This test is a screening tool to identify infants who need further testing to confirm the diagnosis.
Today's Top News Stories | • | FDA Backs Cholesterol Drug Vytorin - Jan 08, 2009, 17:00
Review says it lowered bad cholesterol more effectively than Zocor. | • | Many Turn Blind Eye to Racism - Jan 08, 2009, 17:00
They're not quick to condemn hurtful comments, study suggests. | • | Clinical Trials Update: Jan. 8, 2009 - Jan 08, 2009, 10:12
- Rheumatoid Arthritis
- Neurologic Disorders
- Seizure Disorders
| • | Protein Might One Day Prevent Blindness - Jan 08, 2009, 14:00
Researchers find it prolongs lives of key vision cells in mice. | • | Inflammation Markers May Help Predict Stroke Risk - Jan 08, 2009, 16:00
They should be used when assessing traditional risk factors, experts say. |
|
